DONATE TODAY
To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.
The meeting was recorded. A highlights video is available as well as videos for the individual persentations, see below.
Highlights Video
Next Event - May 2024
11:00am - 1:30pm PST
Virtual Event via Zoom
REGISTRATION OPENS IN APRIL 2024

"You can't know  about things you have yet to discover."

Yogi Berra

MEET WITH OTHER PATIENTS, FAMILY MEMBERS, & CAREGIVERS

ASK QUESTIONS & FIND ANSWERS

KEYNOTE SPEAKER

Dr. Nader Sanai

Dr. Sanai is an internationally recognized brain tumor surgeon and the Chief Scientific Officer/Director of the Ivy Brain Tumor Center at the Barrow Neurological Institute. His specialty clinical practice is devoted entirely to patients with benign and malignant brain tumors, particularly those in high-risk areas.

Dr. Nader Sanai discusses the early testing of new cancer treatments for individual patients based genetic screening techniques. This so-called Phase-0 testing approach enables the rapid evaluation of new therapies. These trials look for therapies with significant impact on the cancers with minimal side effects.

*Please see his 2022 Video Presentation Below
Ivy brain tumor center
Dr. Sanai seminar quad chart
SPEAKER

Dr. Ondrej Choutka

Dr. Ondrej Choutka is a Complex Cranial Neurosurgeon at the Saint Alphonsus Neuroscience Institute. He is devoted to helping his patients. “My reward in neurosurgery is being on the journey with my patient, getting to know them as a person and watching them walk out the door happy and better."

Dr. Ondrej Choutka described a surgically targeted radiation therapy for brain cancer. Specifically, he discussed GammaTile, which is a collagen sponge containing radioactive cesium that is implanted in the brain during cancer surgery. This technique delivers a controlled dose of radiation to the cancer cells with minimal impact on the surrounding tissues.

*Dr. Choutka's 2022 Presentation is shown below:

Dr. Choutka and his work
SPEAKER

Dr. Leo Lustgarten

Dr. Leo Lustgarten is the US Director for Neuro-Oncology and Global Clinical Lead for Novocure. For over 20 years in Venezuela, as a neurosurgeon and radiosurgeon, Dr. Lustgarten performed surgeries on brain tumors, both in adult and pediatric patients, as well as stereotactic procedures.

Dr. Lustgarten described a cancer treatment that uses electric fields to interfere with cell division in solid tumors. The therapy is delivered through an external transducer array connected to a portable delivery system.

*2022 Video Presentation below:
Novocure logo
Dr. Lustgarten and his work
Fran Noonan photo

During this event, our 2022 HOPE Award winner was announced!

Please nominate a Brain Tumor Patient who inspires you. Nominations for the 2024 award open in April 2024. Click the button below to nominate.
NOMINATION FORM
Hope logos

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
heartenvelopeusersphonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram